SETD7
| Official symbol: | SETD7 |
| Full name: | SET domain containing lysine methyltransferase 7 |
| Location: | 4q31.1 |
| Also known as: | KMT7, KIAA1717, SET7/9, SET7, Set9 |
| Entrez ID: | 80854 |
| Ensembl ID: | ENSG00000145391 |
| Summary: | |
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
| Gscore (Amp): | 0.00 | | Gscore (Del): | 0.00 |
|
|
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
|
| |
|
|
|
| |
Overall
|
|
Tissue specific
|
| |
| Total fusion occurrence: | 2 |
|
|
| Fusions detected in 2 cancer type(s) |
|
| |
|
|
|
| Functional class: | Epigenetic |
| JensenLab PubMed score: | 139.85 (Percentile rank: 77.19%) |
| PubTator score: | 74.97 (Percentile rank: 73.96%) |
| Target development/druggability level: | TchemThese targets have activities in ChEMBL or DrugCentral that satisfy the activity thresholds detailed below. |
| Tractability (small molecule): | Discovery PrecedenceTargets with ligands; Targets with crystal structures with ligands |
| Tractability (antibody): | |
